Immunoreactivity in lung cancer.
Lung cancer has been associated with suppression of the cellular immune system. Recent experimental evidence suggests that recognition of HLA class I molecules by cytolytic T lymphocytes is important for tumor resistance. Augmentation of this interaction may soon play a role in cancer therapy.